Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.

of the Clinical Problem Hypertension is a leading risk factor formortality anddisability. Recent estimates are that 874 million adults worldwide have an SBP of 140mmHgorhigher.1,2With itsassociationwithCVD,stroke(cerebrovascular accident [CVA]), heart failure, and chronic kidney disease (CKD), hypertension is second only to cigarette smokingasapreventablecauseofdeath in theUnitedStates.3Given demographic trends and the increasing prevalence of hypertensionwith increasing age (79%ofmenand85%ofwomen>75years old have hypertension), the consequences of hypertension are expected to increase.1,2 Characteristics of the Guideline Source This guideline was developed by the ACC and the AHA in partnershipwith other professional societies. The ACC/AHA Task Force on Clinical Practice Guidelines selected a writing committee that was notable for its inclusion of people with a breadth of backgrounds, wide scopeof practice, and freedom fromconflicts of interest. This writing committee reviewed the relevant evidence and commissionedan independent evidence reviewcommittee to conduct formal systematic reviews regarding 4 questions of critical importance. The guideline document was reviewed by individuals representing the partner specialty societies and other content reviewers. Thewriting committeewas aware of any conflicts of interest among reviewers (Table). Viewpoint and Editorial GUIDELINE TITLE 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, andManagement of High Blood Pressure in Adults